Virotrenz Tablet is a combination of three antiviral medicines: Emtricitabine, Tenofovir disoproxil fumarate and Efavirenz. They work by preventing HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAPrescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHACaution is advised when consuming alcohol with Virotrenz Tablet. Please consult your doctor.
Virotrenz Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Virotrenz Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Virotrenz Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Virotrenz Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Virotrenz Tablet may not be needed in these patients. Please consult your doctor.
Virotrenz Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Virotrenz Tablet may not be needed in these patients. Please consult your doctor.